antiviral news
Press Releases in the global landscape
Dec 31, 2025
Govt bans manufacture, sale of oral formulations containing nimesulide above 100 mg-Here's why
The Indian government enforced a ban on oral nimesulide above 100 mg following ICMR advice, citing liver toxicity and public health risks.
Read More »
Dec 31, 2025
India bans oral Nimesulide over 100 mg
India’s health ministry banned oral formulations of nimesulide above 100 mg due to safety concerns, including liver toxicity, citing availability of safer alternatives.
Read More »
Dec 31, 2025
Nimesulide banned: Govt puts a stop to manufacture, sale of all oral formulations containing the popular painkiller above 100 mg
Following recommendations from ICMR, the Indian government halted the manufacture and sale of high-dose oral nimesulide formulations over safety risks.
Read More »
Dec 17, 2025
Traws Pharma Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID™, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients
Ratutrelvir shows a differentiated profile versus PAXLOVID™ with fewer adverse events and no viral rebounds.
Read More »
Dec 16, 2025
Paxlovid linked to fewer lost workdays, disability claims in employees at high-risk for severe COVID
Employees who took the antiviral drug had 5% fewer workday absences.
Read More »
Dec 10, 2025
Dear Doctor: Was my doctor off base when he told me Paxlovid cures COVID, so I don’t need to be vaccinated
A medical advice column clarifies that COVID-19 prevention through vaccination is superior to treatment alone, countering misconceptions about antiviral drugs replacing vaccines.
Read More »